|
AU2011231975B2
(en)
*
|
2010-03-22 |
2014-07-03 |
Bayer Intellectual Property Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
CN103930399B
(zh)
|
2011-09-16 |
2016-03-16 |
拜耳知识产权有限责任公司 |
包含亚氨基亚磺酰基的二取代的5-氟嘧啶衍生物
|
|
ES2587284T3
(es)
|
2011-09-16 |
2016-10-21 |
Bayer Intellectual Property Gmbh |
5-Fluoro-pirimidinas 2,4-disustituidas como inhibidores selectivos de CDK9
|
|
US8598937B2
(en)
|
2011-10-07 |
2013-12-03 |
Transphorm Inc. |
High power semiconductor electronic components with increased reliability
|
|
US8803246B2
(en)
|
2012-07-16 |
2014-08-12 |
Transphorm Inc. |
Semiconductor electronic components with integrated current limiters
|
|
CA2888383A1
(en)
*
|
2012-10-18 |
2014-04-24 |
Bayer Pharma Aktiengesellschaft |
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
|
|
HK1213890A1
(zh)
|
2012-10-18 |
2016-07-15 |
Bayer Pharma Aktiengesellschaft |
含碸基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
CN104854091B
(zh)
|
2012-10-18 |
2018-04-03 |
拜耳药业股份公司 |
含砜基团的5‑氟‑n‑(吡啶‑2‑基)吡啶‑2‑胺衍生物
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
MX374333B
(es)
|
2012-11-15 |
2025-03-06 |
Bayer Pharma AG |
Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina.
|
|
US9087718B2
(en)
|
2013-03-13 |
2015-07-21 |
Transphorm Inc. |
Enhancement-mode III-nitride devices
|
|
US9245992B2
(en)
|
2013-03-15 |
2016-01-26 |
Transphorm Inc. |
Carbon doping semiconductor devices
|
|
CN105492438B
(zh)
|
2013-07-04 |
2018-08-07 |
拜耳医药股份有限公司 |
磺亚胺取代的5-氟-n-(吡啶-2-基)吡啶-2-胺衍生物以及其作为cdk9激酶抑制剂的用途
|
|
US9443938B2
(en)
|
2013-07-19 |
2016-09-13 |
Transphorm Inc. |
III-nitride transistor including a p-type depleting layer
|
|
CN106232596A
(zh)
|
2014-03-13 |
2016-12-14 |
拜耳医药股份有限公司 |
含有砜基团的5‑氟‑n‑(吡啶‑2‑基)吡啶‑2‑胺衍生物
|
|
CN106414412B
(zh)
|
2014-04-01 |
2019-06-21 |
拜耳医药股份有限公司 |
含有磺酰二亚胺基团的二取代的5-氟嘧啶衍生物
|
|
CR20160471A
(es)
|
2014-04-11 |
2016-12-21 |
Bayer Pharma AG |
Compuestos novedosos macrocíclicos
|
|
US9543940B2
(en)
|
2014-07-03 |
2017-01-10 |
Transphorm Inc. |
Switching circuits having ferrite beads
|
|
US9318593B2
(en)
|
2014-07-21 |
2016-04-19 |
Transphorm Inc. |
Forming enhancement mode III-nitride devices
|
|
WO2016059086A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
CA2964683A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
CN107427520A
(zh)
|
2015-03-24 |
2017-12-01 |
拜耳医药股份有限公司 |
4‑(4‑氟‑2‑甲氧基苯基)‑n‑{3‑[(s‑甲基磺酰亚氨基)甲基]苯基}‑1，3，5‑三嗪‑2‑胺用于治疗淋巴瘤的用途
|
|
WO2016150893A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
LT3313838T
(lt)
|
2015-06-29 |
2019-06-10 |
Astrazeneca Ab |
Policikliniai amido dariniai, kaip cdk9 slopikliai
|
|
EP3356373B1
(en)
|
2015-09-29 |
2020-02-19 |
Bayer Pharma Aktiengesellschaft |
Novel macrocyclic sulfondiimine compounds
|
|
CN108368129B
(zh)
|
2015-10-08 |
2021-08-17 |
拜耳医药股份有限公司 |
改性大环化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
JP6888013B2
(ja)
|
2016-01-15 |
2021-06-16 |
トランスフォーム テクノロジー，インコーポレーテッド |
ＡＬ（１−ｘ）Ｓｉ（ｘ）Ｏゲート絶縁体を有するエンハンスメントモードＩＩＩ族窒化物デバイス
|
|
TWI813243B
(zh)
|
2016-05-31 |
2023-08-21 |
美商創世舫科技有限公司 |
包含漸變空乏層的三族氮化物裝置
|
|
CA3057891A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
US11254690B2
(en)
|
2017-03-28 |
2022-02-22 |
Bayer Pharma Aktiengesellschaft |
PTEFb inhibiting macrocyclic compounds
|
|
MA51820A
(fr)
|
2018-02-13 |
2021-05-19 |
Bayer Ag |
Utilisation de 5-fluoro-4-(4-fluoro-2-méthoxyphényl)-n-(4-[(s-méthylsulfonimidoyl)méthyl]pyridin-2-yl)pyridin-2-amine pour traiter un lymphome diffus à grandes cellules b
|